Lifestance Health
LFST
130 hedge funds and large institutions have $2.3B invested in Lifestance Health in 2024 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 58 increasing their positions, 28 reducing their positions, and 27 closing their positions.
174% more call options, than puts
Call options by funds: $24.7M | Put options by funds: $9.02M
107% more repeat investments, than reductions
Existing positions increased: 58 | Existing positions reduced: 28
43% more capital invested
Capital invested by funds: $1.61B → $2.3B (+$697M)
0.42% more ownership
Funds ownership: 85.57% → 85.98% (+0.42%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
2% less funds holding
Funds holding: 133 → 130 (-3)
11% less first-time investments, than exits
New positions opened: 24 | Existing positions closed: 27
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$15.3M |
| 2 |
BlackRock
New York
|
+$15M |
| 3 |
Morgan Stanley
New York
|
+$13.3M |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
+$7.95M |
| 5 |
Barclays
London,
United Kingdom
|
+$7.15M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$40.9M |
| 2 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$14.8M |
| 3 |
DCP
Durable Capital Partners
Bethesda,
Maryland
|
-$11.7M |
| 4 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$10.4M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$4.91M |
LFST Hedge Fund Activity: Q3 2024 in Review
130 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Lifestance Health (LFST) for Q3 2024, worth a combined $2.3B — up 43% from $1.61B a quarter earlier.
Sellers outnumbered buyers: 27 funds closed out of LFST and 24 opened new positions — a net loss of 3 holders — while 28 trimmed existing stakes and 58 added.
The largest buyer was Goldman Sachs, adding an estimated $15.3M. The largest seller was Fidelity Investments, cutting an estimated $40.9M.
- 130 institutional investors held Lifestance Health (LFST) as of Q3 2024, down from 133 in Q2 2024.
- Funds reported $2.3B of Lifestance Health stock for Q3 2024, up 43% quarter-over-quarter.
- 24 funds opened new Lifestance Health positions in Q3 2024 and 27 closed out, a net change of -3 holders.
- The largest Lifestance Health buyer in Q3 2024 was Goldman Sachs, an estimated $15.3M added.
- The largest Lifestance Health seller in Q3 2024 was Fidelity Investments, an estimated $40.9M sold.
Based on aggregated 13F filings for Q3 2024.